Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer

  Free Subscription


18.05.2026

1 AJPM Focus
1 Anticancer Agents Med Chem
1 Appl Biochem Biotechnol
1 Arch Gynecol Obstet
1 Arch Virol
1 BMC Health Serv Res
2 BMC Womens Health
1 Cancer Control
1 Cancer Med
2 Cancers (Basel)
2 Cell Signal
1 Cells
1 Cir Cir
1 Clin Oncol (R Coll Radiol)
1 Clinics (Sao Paulo)
1 Comput Biol Chem
1 Comput Struct Biotechnol J
1 EBioMedicine
1 Ecancermedicalscience
1 Eur J Obstet Gynecol Reprod Biol
1 Expert Rev Mol Diagn
1 Expert Rev Vaccines
2 Front Immunol
3 Front Oncol
3 Front Public Health
1 Ginekol Pol
1 Gynecol Oncol
1 Implement Sci Commun
1 In Silico Pharmacol
1 Indian J Dermatol
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
2 Int J Mol Sci
2 Int J Surg Pathol
1 Iran J Allergy Asthma Immunol
1 J Adv Nurs
1 J Appl Clin Med Phys
2 J Cancer Educ
1 J Clin Med
1 J Gen Intern Med
2 J Gynecol Oncol
1 J Med Virol
1 J Midlife Health
1 J Obstet Gynaecol Res
1 J Prim Care Community Health
1 J Public Health Afr
1 J Robot Surg
1 J Womens Health (Larchmt)
1 JAMA Intern Med
1 Lancet Reg Health Am
1 Math Biosci Eng
2 Medicine (Baltimore)
1 Narra J
1 Onco Targets Ther
1 PeerJ
2 Pract Radiat Oncol
1 Public Health Pract (Oxf)
1 Public Health Rep
1 Scand J Public Health
3 Sci Rep
1 Surg Oncol
1 Technol Cancer Res Treat
1 West J Nurs Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJPM Focus

  1. KAUL IK, Garber BL, Koch TL, Altomare AL, et al
    Understanding Barriers to Cervical Cancer Screening: A Quality Improvement Project in the HIV Clinics at Dartmouth Health.
    AJPM Focus. 2026;5:100488.
    PubMed         Abstract available


    Anticancer Agents Med Chem

  2. TRIPATHI T, Joshi U, Chaudhary A, Janjua D, et al
    Morusin Attenuates Cancer Stemness and Modulates CSC-driven Macrophage Polarization in Cervical Cancer.
    Anticancer Agents Med Chem. 2026.
    PubMed         Abstract available


    Appl Biochem Biotechnol

  3. HABIBA U, Ayaz M, Islam N
    Machine Learning-driven Prediction of Cervical Cancer Cell Viability After Treatment With Thymoquinone, Curcumin, and 5-Fluorouracil.
    Appl Biochem Biotechnol. 2026 May 9. doi: 10.1007/s12010-026-05704.
    PubMed         Abstract available


    Arch Gynecol Obstet

  4. ARNO A, Pernazza A, Leopizzi M, Benedettucci E, et al
    Clinical relevance and prognostic role of PDL-1 expression in cervical cancer patients.
    Arch Gynecol Obstet. 2026;313:193.
    PubMed        


    Arch Virol

  5. SACHIT BA, Dass S, Rajan RS, Tye GJ, et al
    Integrated in silico-in vitro identification of high-affinity TCR-Like antibodies targeting HPV18 E6/E7 for cervical cancer detection.
    Arch Virol. 2026;171:177.
    PubMed         Abstract available


    BMC Health Serv Res

  6. SOYLER S, Sipahi BB, Cavmak D
    Exploring barriers to women's participation in breast and cervical cancer screening programs: insights from national health surveys in Turkiye.
    BMC Health Serv Res. 2026 May 7. doi: 10.1186/s12913-026-14656.
    PubMed         Abstract available


    BMC Womens Health

  7. PAHRIA T, Haroen H, Agustina HR, Sari CWM, et al
    Women's experiences toward cervical cancer care at the initiation of care: a qualitative study closing the gap policy and implementation in Indonesia.
    BMC Womens Health. 2026 May 13. doi: 10.1186/s12905-026-04493.
    PubMed         Abstract available

  8. HELLSTEN C, Magnusson L, Borgfeldt C
    Women's reasoning and experience in the cervical cancer screening programme when offered a self-sampling HPV test: a qualitative content analysis.
    BMC Womens Health. 2026;26:239.
    PubMed         Abstract available


    Cancer Control

  9. KANG Y, Zhuang L, Chang L, Liu J, et al
    The Prognosis of Patients With Large Cell Carcinoma of the Cervix: A Retrospective Study of the SEER Database and a Chinese Multi-Center Registry.
    Cancer Control. 2026;33:10732748261449853.
    PubMed         Abstract available


    Cancer Med

  10. COMMEH ME, Husain N, Afrane CB, Apatu M, et al
    Partnership Driving Impact: An Integrated Women-Centric Model to Improve Early Detection and Treatment of Cervical and Breast Cancer in Ghana and India.
    Cancer Med. 2026;15:e71890.
    PubMed         Abstract available


    Cancers (Basel)

  11. TIAN D, Du M, Zheng Z, Wang W, et al
    NSUN4 Suppresses Ferroptosis Through m(5)C-Dependent Stabilization of C-MYC and Activation of the PI3K/Akt Signaling Pathway in Cervical Cancer.
    Cancers (Basel). 2026;18:1392.
    PubMed         Abstract available

  12. JURCZAK M, Charzewski L, Gozlinska B, Albrycht P, et al
    Artificial Intelligence-Assisted Colposcopy: Deep Learning Multi-Class Segmentation of Anatomical Structures and Pathological Findings for Cervical Cancer Screening.
    Cancers (Basel). 2026;18:1485.
    PubMed         Abstract available


    Cell Signal

  13. QI L, Zhu D, Qian L, Yi B, et al
    SIRT1-mediated deacetylation stabilizes cortactin to enhance glycolysis and drive cervical cancer progression.
    Cell Signal. 2026 May 9:112587. doi: 10.1016/j.cellsig.2026.112587.
    PubMed         Abstract available

  14. XIE T, He Y, Tan M, Gao Y, et al
    Caprin-1 silencing reverses YY1/HSP90alpha-mediated IDH1 stabilization to induce ferroptosis and sensitize cervical cancer to cisplatin.
    Cell Signal. 2026;145:112584.
    PubMed         Abstract available


    Cells

  15. TAMENANG A, Vohl V, Schwartz C, Kropidlowski J, et al
    Circulating microRNA Profiles as Diagnostic Tools for High-Grade Cervical Lesions and HPV Genotype Stratification.
    Cells. 2026;15:849.
    PubMed         Abstract available


    Cir Cir

  16. DEL REAL-ORDONEZ S, Reynoso-Noveron N, Perez-Montiel MD, Salcedo-Hernandez RA, et al
    [Sensitivity and validity of sentinel node biopsy in early-stage cervical cancer at an oncology institution].
    Cir Cir. 2026 May 13. doi: 10.24875/CIRU.24000532.
    PubMed         Abstract available


    Clin Oncol (R Coll Radiol)

  17. KULKARNI V, Jaiswal A, Kshirsagar N, Arya M, et al
    Accelerated MRI-Guided Brachytherapy in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2026;55:104172.
    PubMed        


    Clinics (Sao Paulo)

  18. DE OLIVEIRA HF, de Souza FD
    Comment on: "The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer".
    Clinics (Sao Paulo). 2026;81:100953.
    PubMed        


    Comput Biol Chem

  19. BAHRUN, Melanie H, Artanti N, Anita Y, et al
    Integrated In vitro, network pharmacology, and In silico analysis reveal the anti-cervical cancer properties of calcareous green algae Halimeda sp.
    Comput Biol Chem. 2026;124.
    PubMed         Abstract available


    Comput Struct Biotechnol J

  20. WAN M, Zhong T, Shi W, Shen J, et al
    PRDM1 Is Associated with Chemoradiotherapy-Associated Enrichment of Adaptive NK Cells in Cervical Cancer.
    Comput Struct Biotechnol J. 2026;35:0092.
    PubMed         Abstract available


    EBioMedicine

  21. LIN S, Luo Z, Li Y, Hu B, et al
    Integrated spatial multi-omics delineates fatty acid degradation fuels malignant evolution at the tumour periphery in cervical squamous cell carcinoma.
    EBioMedicine. 2026;127:106256.
    PubMed         Abstract available


    Ecancermedicalscience

  22. CHEMA TZ, Woldetsadik ES, Zingeta GT, Bedada HF, et al
    Symptom palliation with QUADSHOT regimen for advanced cervical cancer patients in Tikur Anbessa Specialised Hospital: a prospective cohort study.
    Ecancermedicalscience. 2026;20:2085.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  23. OSAWA N, Chikazawa K, Ko H, Kuwata T, et al
    Follow-up by resident physicians is associated with underuse of hormone replacement therapy after cervical cancer treatment: A retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2026;323:115170.
    PubMed         Abstract available


    Expert Rev Mol Diagn

  24. MBOUMBA BOUASSA RS, Muwonga Tukisadila J, Loemba H, Belec L, et al
    Human papillomavirus viral load as promising surrogate biomarker of cervical cancer risk and clinical outcome.
    Expert Rev Mol Diagn. 2026 May 14. doi: 10.1080/14737159.2026.2675388.
    PubMed         Abstract available


    Expert Rev Vaccines

  25. ZELEKE AJ, Reifferscheid L, Yunusa U, Gandhi K, et al
    Population-level impact of HPV vaccination: a global systematic review of ecological, cross-sectional, and cohort studies.
    Expert Rev Vaccines. 2026;25:2667734.
    PubMed         Abstract available


    Front Immunol

  26. LIN J, He H, Liu B, He T, et al
    The exploration of iparomlimab and tuvonralimab combined with de-escalated chemotherapy as an innovative neoadjuvant treatment strategy for locally advanced cervical cancer: a case report from the NICE-CC trial.
    Front Immunol. 2026;17:1801164.
    PubMed         Abstract available

  27. LIAN X, Qi H, Lin D, Wu Q, et al
    Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study.
    Front Immunol. 2026;17:1723923.
    PubMed         Abstract available


    Front Oncol

  28. XIAO H, Qu A, Sun H, Zhang X, et al
    Dosimetric impact of two multileaf collimator systems in simultaneous integrated boost volumetric modulated arc therapy for lymph node metastases in stage IIIC cervical cancer.
    Front Oncol. 2026;16:1805020.
    PubMed         Abstract available

  29. WANG X, Xiong D, Cui S, Duan B, et al
    Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015-2024.
    Front Oncol. 2026;16:1732209.
    PubMed         Abstract available

  30. WANG Y, Yue ZN, Yang H
    Impact of adjuvant therapy after radical hysterectomy for early-stage cervical cancer on mortality and recurrence: a systematic review and meta-analysis.
    Front Oncol. 2026;16:1743116.
    PubMed         Abstract available


    Front Public Health

  31. GUZELBAG B, Uzuner EG, Selcuk M, Ermin S, et al
    Twelve-year trends in cervical cytology screening: a retrospective analysis of 83,148 smears from a Turkish tertiary care center.
    Front Public Health. 2026;14:1818289.
    PubMed         Abstract available

  32. ZHOU J, Liao JH, Su LJ, Chen Y, et al
    Informative HPV testing after conization and its impact on time-varying estimates: a GAMM-based cohort study.
    Front Public Health. 2026;14:1808122.
    PubMed         Abstract available

  33. XU S, Li Y, Yi X, Yan Z, et al
    Nationwide epidemiology of HPV E6/E7 mRNA in China: genotype distribution in 11,118 women.
    Front Public Health. 2026;14:1797051.
    PubMed         Abstract available


    Ginekol Pol

  34. BAK P, Ciechacka M, Al-Jeabory M, Ziemianska JK, et al
    Adaptation to neoplastic disease among women diagnosed with breast cancer and cervical cancer, taking into account the type of surgical procedure and sociodemographic factors.
    Ginekol Pol. 2026;97:297-304.
    PubMed         Abstract available


    Gynecol Oncol

  35. BORKAR SR, Tasman JG, Bakkum-Gamez JN, Cheney MC, et al
    Exploring delays in primary gynecologic and breast cancer diagnosis after emergency department presentation.
    Gynecol Oncol. 2026;208:41-47.
    PubMed         Abstract available


    Implement Sci Commun

  36. BRUNISSEN L, Diwan NM, Kocher EL, Suvada K, et al
    Provider attitudes and organizational support for cervical cancer screening implementation across PEPFAR-supported HIV clinics in Kenya.
    Implement Sci Commun. 2026 May 13. doi: 10.1186/s43058-026-00958.
    PubMed         Abstract available


    In Silico Pharmacol

  37. LOSHNI V, Lakshmi T, Balaji R
    GC?MS analysis, molecular docking, molecular dynamics simulation, and pharmacokinetic profiling of bioactive compounds from Terminalia bellirica seeds against cervical cancer targets.
    In Silico Pharmacol. 2026;14:136.
    PubMed         Abstract available


    Indian J Dermatol

  38. LEE KH, Jeong JH, Park CJ, Kim YS, et al
    Extensive Grouped Papules on the Vulva in a Patient with Cervical Cancer.
    Indian J Dermatol. 2026;71:256.
    PubMed        


    Int J Gynaecol Obstet

  39. WATCHARASIN P, Sirimusika N, Atjimakul T, Rattanaburi A, et al
    Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2026;173:1617-1627.
    PubMed         Abstract available


    Int J Gynecol Cancer

  40. CHEN Z, Zeng Y, Luo L, Li J, et al
    Multi-center-validated machine learning model for cervical cancer based on human papillomavirus genotyping results.
    Int J Gynecol Cancer. 2025;36:102855.
    PubMed         Abstract available


    Int J Mol Sci

  41. GREEGRAINUCH K, Kansandee W, Pientong C, Ekalaksananan T, et al
    Antiviral and Anticancer Activities of Stingless Bee Propolis from Tetragonula drescheri and Tetragonula pagdeni: Toward Development of Prototype Healthcare Pharmaceuticals.
    Int J Mol Sci. 2026;27:3855.
    PubMed         Abstract available

  42. MASOUD M, Shastri C, Banerjee R, Dasgupta S, et al
    Genome-Wide DNA Methylation Profiling Reveals Ancestry-Associated Epigenetic Reprogramming in Cervical Intraepithelial Neoplasia.
    Int J Mol Sci. 2026;27:3986.
    PubMed         Abstract available


    Int J Surg Pathol

  43. PEREZ AN, Curry JL, Madewell JE, Meis JM, et al
    Florid Pseudosarcomatous Polypoid Fibroplasia: An Unusual Cutaneous Manifestation of Chronic Lymphedema.
    Int J Surg Pathol. 2026;34:970-975.
    PubMed         Abstract available

  44. BENDARI A, Ahsan BU, Mohammed H, Al-Refai R, et al
    Clinicopathologic Features of Six Patients With Metastatic Carcinoma to the Uterine Cervix.
    Int J Surg Pathol. 2026;34:997-1006.
    PubMed         Abstract available


    Iran J Allergy Asthma Immunol

  45. RAHAVI H, Najafi A, Asgarian-Omran H, Aflatoonian B, et al
    Dual Blockade of PD-L1 and AXL: A Novel Immunotherapeutic Approach for Ovarian and Cervical Cancer.
    Iran J Allergy Asthma Immunol. 2026;25:234-250.
    PubMed         Abstract available


    J Adv Nurs

  46. SAUNDERS T, Boyd L, Machado Colling A, He J, et al
    Nurse Roles Implementing the Choice for Self-Collection Cervical Screening in Rural Settings: A Qualitative Study Following National Policy Change.
    J Adv Nurs. 2026;82:6543-6556.
    PubMed         Abstract available


    J Appl Clin Med Phys

  47. WANG Z, Zhang W, Meng X, Liang Y, et al
    Test-time adaptation-driven patient-specific auto-segmentation for CBCT-guided online adaptive radiotherapy in cervical cancer.
    J Appl Clin Med Phys. 2026;27:e70609.
    PubMed         Abstract available


    J Cancer Educ

  48. MINAMITANI M, Katano A, Ohira S, Hayashi T, et al
    Evaluating Behavioral Impacts of School Cancer Education Programs Several Months and Years After Implementation in Japan.
    J Cancer Educ. 2026;41:270-276.
    PubMed         Abstract available

  49. THOMPSON EL, Griner SB, Akpan IN, Maness SB, et al
    HPV Vaccination Knowledge, Attitudes, and Behaviors Among Clinic Teams in North Texas.
    J Cancer Educ. 2026;41:296-301.
    PubMed         Abstract available


    J Clin Med

  50. YIN L, Lv F
    Ultrasound-Clinical Machine Learning Models for Differentiating Early Cervical Cancer from Myoma: A Retrospective Exploratory Study.
    J Clin Med. 2026;15:3300.
    PubMed         Abstract available


    J Gen Intern Med

  51. HALM EA, Del Vecchio NJ, Rendle KA, Tiro JA, et al
    Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium.
    J Gen Intern Med. 2026;41:1761-1770.
    PubMed         Abstract available


    J Gynecol Oncol

  52. ZHAO X, Chang L, Duan W, Liu L, et al
    HPV E6/E7 mRNA vs. HPV DNA in co-testing with ThinPrep cytology for cervical cancer screening: a prospective observational diagnostic accuracy study of methylation biomarkers.
    J Gynecol Oncol. 2026 Apr 22. doi: 10.3802/jgo.2026.
    PubMed         Abstract available

  53. MATSUNAGA A, Ogawa M, Kunita A, Ikeda Y, et al
    Type-specific detection and quantification of circulating tumor HPV DNA by digital PCR in surgically resected cervical cancer.
    J Gynecol Oncol. 2026 Apr 22. doi: 10.3802/jgo.2026.
    PubMed         Abstract available


    J Med Virol

  54. XI M, Ao M, Li J, Zhang S, et al
    Risk of High-Grade Cervical Intraepithelial Neoplasia Using human Papillomavirus Extended Genotyping in Chinese Women With Normal Cervical Cytology: A Population-Based Screening Cohort.
    J Med Virol. 2026;98:e70968.
    PubMed         Abstract available


    J Midlife Health

  55. AGRAWAL A, Archana, Shakya P, Verma U, et al
    Evaluation of Different Diagnostic Modalities for Screening and Molecular Characterization of Human Papillomavirus Causing Cervical Cancer.
    J Midlife Health. 2026;17:111-116.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  56. ZHAO J, Li Z, Qiu H, Wang J, et al
    Gastric-Type Adenocarcinoma of the Uterine Cervix From 2013 to 2023: Clinical Characteristics and Outcomes.
    J Obstet Gynaecol Res. 2026;52:e70316.
    PubMed         Abstract available


    J Prim Care Community Health

  57. ADEPOJU OE, Xu T, Ramirez-Pulido G, Angelocci T, et al
    Individual and Co-Occurring Social Needs, and Breast and Cervical Cancer Screening Among Patients in Texas Federally Qualified Health Centers.
    J Prim Care Community Health. 2026;17:21501319261448952.
    PubMed         Abstract available


    J Public Health Afr

  58. NDAKUKAMO EK, Mahalie R, Hailonga-Van Dijk P
    Health-seeking behaviour of rural women regarding cervical cancer prevention in Namibia: A qualitative study.
    J Public Health Afr. 2026;17:1632.
    PubMed         Abstract available


    J Robot Surg

  59. YU H, Liang H, Liang X, Lin H, et al
    The influence of robotic-assisted systems on the surgical approach and outcomes in hysterectomy for benign and malignant diseases.
    J Robot Surg. 2026;20:484.
    PubMed         Abstract available


    J Womens Health (Larchmt)

  60. WONG L, Munigala S, Banaag A, Coles C, et al
    Guideline Concordant Cervical Cancer Screening Among Active-Duty Servicewomen in the U.S. Military from 2017 to 2022.
    J Womens Health (Larchmt). 2026 May 14:15409996261443156.
    PubMed         Abstract available


    JAMA Intern Med

  61. HOLT HK, Ransohoff AK, Sawaya GF
    Self-Collected HPV Testing for Cervical Cancer Screening-Responsible Implementation to Reduce Disparities.
    JAMA Intern Med. 2026 May 11. doi: 10.1001/jamainternmed.2026.1212.
    PubMed        


    Lancet Reg Health Am

  62. TEJADA R, Baena A, Trujillo L, Rodriguez J, et al
    Impact of switching from a quadrivalent to a nonavalent HPV vaccine on HPV infections and cervical cancer in Colombia: a mathematical modelling study.
    Lancet Reg Health Am. 2026;58:101483.
    PubMed         Abstract available


    Math Biosci Eng

  63. FODJO MT, Youmbi AK, Mayeh M, Whegang S, et al
    Modeling the impact of budget limitation on the screening and treatment pathway of HPV-induced precancerous cervical lesions.
    Math Biosci Eng. 2026;23:1501-1533.
    PubMed         Abstract available


    Medicine (Baltimore)

  64. LI J, Wang Y, Xu Z, Ao S, et al
    Comparative analysis of cervical cancer burden trends between China and G20 countries from 1990 to 2023 with projections to 2035: A population-based observational study.
    Medicine (Baltimore). 2026;105:e48640.
    PubMed         Abstract available

  65. LIU H, Huang F, Da H, Yin Q, et al
    Absence of causal association between CD40-CD40L signaling and cervical cancer risk: A Mendelian randomization study.
    Medicine (Baltimore). 2026;105:e48638.
    PubMed         Abstract available


    Narra J

  66. YOLANDA F, Dewi TP, Nainggolan SI, Munawar M, et al
    Multi-stakeholder perspectives on cervical cancer screening implementation in Indonesia: A qualitative study of cervical screening barriers in Banda Aceh.
    Narra J. 2026;6:e3022.
    PubMed         Abstract available


    Onco Targets Ther


  67. MiR-155-5p Accelerates the Metastasis of Cervical Cancer Cell via Targeting TP53INP1 [Retraction].
    Onco Targets Ther. 2026;19:620871.
    PubMed         Abstract available


    PeerJ

  68. ZHANG Y, Xing W, Liang X, Ma Y, et al
    A retrospective analysis of the prognostic value of nutritional-inflammatory markers for patients with cervical cancer.
    PeerJ. 2026;14:e21273.
    PubMed         Abstract available


    Pract Radiat Oncol

  69. RIGGENBACH E, Tadic T, Han K
    Uterine ultra-mover in cervical cancer radiotherapy: retroversion and the rationale for online adaptive planning.
    Pract Radiat Oncol. 2026 May 8:S1879-8500(26)00137.
    PubMed        

  70. HAN Y, Wang C, Wang X, Sun S, et al
    Clinical Implementation of Dual-Isocenter MR-Guided Radiotherapy for Large-Target Cervical Cancer: A Dosimetric and Workflow Analysis.
    Pract Radiat Oncol. 2026 May 9:S1879-8500(26)00144.
    PubMed         Abstract available


    Public Health Pract (Oxf)

  71. SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
    Impact of the transition to HPV-based primary screening in Portugal's organized cervical cancer screening program: A controlled interrupted time-series analysis (2014-2023).
    Public Health Pract (Oxf). 2026;11:100792.
    PubMed         Abstract available


    Public Health Rep

  72. PAKONEN J, Jensen A, Cruz Zorrilla M, Gutierrez R, et al
    Beyond Free Screening: Structural Barriers to Follow-Up Cervical Cancer Care Among Uninsured Hispanic Women in Minnesota, 2020-2021.
    Public Health Rep. 2026 May 9:333549261442167. doi: 10.1177/00333549261442167.
    PubMed         Abstract available


    Scand J Public Health

  73. JORGENSEN SF, Nielsen ML, Njor SH
    Adherence to recommended follow-up in opportunistic versus non-opportunistic cervical screening: a registry-based cohort study from Denmark.
    Scand J Public Health. 2026;54:297-306.
    PubMed         Abstract available


    Sci Rep

  74. ABDELHAY EH, Elgamily KM, Badr WOE
    Metaheuristic optimization of deep CNNs for multi-class diagnosis of cervical cancer and lymphoma.
    Sci Rep. 2026;16:15110.
    PubMed         Abstract available

  75. KUMAR M, Barmon D, Baruah U, Begum D, et al
    Disease laterality independently predicts survival in stage IIIB cervical cancer in a prospective cohort study from Northeast India.
    Sci Rep. 2026 May 8. doi: 10.1038/s41598-026-48514.
    PubMed         Abstract available

  76. GARG P, Kumar P, Gupta M, Bindal P, et al
    Determinants of cervical cancer screening and HPV vaccination among female medical practitioners in Punjab, India.
    Sci Rep. 2026 May 11. doi: 10.1038/s41598-026-52609.
    PubMed         Abstract available


    Surg Oncol

  77. SIDONIE M, Elisabete G
    Oncologic, pregnancy, and reproductive outcomes of fertility-sparing surgery in early-stage cervical cancer: a systematic review.
    Surg Oncol. 2026;66:102439.
    PubMed         Abstract available


    Technol Cancer Res Treat


  78. Corrigendum to "A Novel Network-Level Fused Self-Attention Deep Neural Network for Cervical Cancer Classification from Cervicography Images".
    Technol Cancer Res Treat. 2026;25:15330338261451109.
    PubMed        


    West J Nurs Res

  79. KWOK C, Endrawes G, Lee CF
    Cervical Cancer Screening Beliefs Questionnaire: Development and Psychometric Assessment With Immigrants in Australia.
    West J Nurs Res. 2026 May 15:1939459261440462. doi: 10.1177/01939459261440462.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum